Related Experiment Video

Updated: Feb 22, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

Future Clinical Trials: Genetically Driven Trials

Igor Astsaturov1

  • 1Department of Hematology and Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Surgical Oncology Clinics of North America
|September 20, 2017
PubMed

Insights

Modern oncology trials match cancer biomarkers to targeted drugs, a shift to clinical cancer biology. This approach uses synthetic lethality, driven by molecular profiling, for mechanism-based drug testing.

Area of Science:

  • Oncology
  • Molecular Biology
  • Clinical Pharmacology

Background:

  • Modern oncology clinical trials are shifting towards personalized medicine.
  • This paradigm, termed clinical cancer biology, focuses on matching molecular biomarkers with targeted therapies.
  • Exploiting synthetic lethality is a key strategy, where a drug targets a specific genetic alteration in cancer cells.

Purpose of the Study:

  • To describe the paradigm shift in oncology clinical trials towards molecularly targeted therapies.
  • To highlight the role of synthetic lethality in developing novel cancer treatments.
  • To discuss the impact of evolving molecular profiling technologies on future clinical trial design.

Main Methods:

  • The abstract describes a conceptual approach rather than specific experimental methods.
  • It emphasizes the reliance on advanced cancer molecular profiling technologies.
  • The approach involves identifying synthetic lethal interactions between genetic alterations and drugs.

Main Results:

  • The abstract does not present specific experimental results.
  • It outlines a strategic direction for future clinical trial design.
  • The focus is on a mechanism-based approach to drug evaluation.

Conclusions:

  • Clinical cancer biology represents a significant advancement in cancer care.
  • Future clinical trials will increasingly rely on molecular mechanisms over traditional histopathology.
  • Technological advancements in molecular profiling are crucial for advancing this approach.
Keywords:
Basket clinical trialBiomarkerMolecular profiling

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
30
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K